Authors
Jitender Nagpal, Swapnil Rawat, Ramasheesh Yadav, Manu Mathur, Rajendra Pant, Anita Shah, Atul Singhal, Mario Cortin Borja, Michelle Heys, Monica Lakhanpaul
Published in
BMJ public health. Volume 4. Issue 4. Pages e006254. Epub Nov 09, 2026.
Abstract
The MATCOBIND trial found a higher mental developmental quotient at 9-12 months in infants of mothers given 250 µg/day rather than 50 µg/day of vitamin B₁₂. We examined whether this difference was distributed across all mental developmental domains or concentrated in particular ones.
Secondary analysis of a multicentre, double-blind randomised controlled trial conducted at two tertiary maternity centres in New Delhi (India) and Kathmandu (Nepal), including 531 mother-infant dyads (250 µg/day n=255; 50 µg/day n=276). Infants were assessed at 9-12 months with the Developmental Assessment Scale for Indian Infants. We compared the two arms on each subdomain that could be meaningfully scored at this age and on two composite groupings: a language grouping (domains VI and VII), the primary outcome and a cognition grouping (domains IV, V and VIII). Each domain score was expressed as a developmental age and as a quotient relative to the child's age. Multiplicity was controlled using the Benjamini-Hochberg false discovery rate.
531 mother-infant dyads were assessed (250 µg/day n=255; 50 µg/day n=276). The language grouping favoured the higher dose: mean difference 2.80 quotient points (95% CI 0.95 to 4.65), and this was the only outcome to meet false discovery rate control on both co-primary representations (q=0.006 and q=0.026). Differences in the individual language domains did not survive adjustment for multiple comparisons (q=0.060). All motor domains, the cognition grouping and the remaining mental domains showed no clear evidence of between-arm differences. Estimates were consistent across sites (interaction p=0.484) and after adjustment for loss to follow-up.
In this exploratory secondary analysis, the difference between arms was concentrated in language-related development. The effect is small, its clinical importance is not established, and the measures are derived rather than validated subscales.
NCT04083560.
PMID:
43022896
Bibliographic data and abstract were imported from PubMed on 13 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 8
- Comments 0